Use App
Trending
News
Earnings
All
DIA
0.86%
SPY
0.56%
QQQ
0.67%
Trending
BB
19.10%
HYLN
40.24%
AKTX
145.53%
QBTS
12.22%
RGTI
18.60%
NIO
6.88%
SIDU
21.79%
FJET
36.70%
BULL
6.58%
NVDA
1.84%
BB
19.10%
HYLN
40.24%
AKTX
145.53%
QBTS
12.22%
RGTI
18.60%
NIO
6.88%
SIDU
21.79%
FJET
36.70%
BULL
6.58%
NVDA
1.84%
home
Symbol
GRI
news
GRI
GRI Bio Inc
6,709
Mkt Cap
$3.9M
Volume
16,796.00
52W High
$80.36
52W Low
$1.97
PE Ratio
-0.03
GRI Fundamentals
Price
$2.13
Prev Close
$2.20
Open
$2.22
50D MA
$2.37
Beta
1.21
Avg. Volume
165,400.34
EPS (Annual)
-$121.80
P/B
0.33
Rev/Employee
$0.00
$7.48
PE Ratio
-0.03
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
<
...
1
>
Compact View
Full View
Mini-Chart
Sentiment
Not available
Message Volume
Not available
Advertisement
|
Remove ads.
Latest GRI News
View
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
Top Discussions
top
active
trending
Loading...
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile